Cargando…
Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report
Long‐chain fatty‐acyl CoA dehydrogenase deficiency (LCHADD) is an inborn error of long chain fatty acid oxidation with various features including hypoketotic hypoglycemia, recurrent rhabdomyolysis, pigmentary retinopathy, peripheral neuropathy, cardiomyopathy, and arrhythmias. Various stresses trigg...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653242/ https://www.ncbi.nlm.nih.gov/pubmed/33204595 http://dx.doi.org/10.1002/jmd2.12165 |
_version_ | 1783607864276811776 |
---|---|
author | Wongkittichote, Parith Watson, James R. Leonard, Jennifer M. Toolan, Elizabeth R. Dickson, Patricia I. Grange, Dorothy K. |
author_facet | Wongkittichote, Parith Watson, James R. Leonard, Jennifer M. Toolan, Elizabeth R. Dickson, Patricia I. Grange, Dorothy K. |
author_sort | Wongkittichote, Parith |
collection | PubMed |
description | Long‐chain fatty‐acyl CoA dehydrogenase deficiency (LCHADD) is an inborn error of long chain fatty acid oxidation with various features including hypoketotic hypoglycemia, recurrent rhabdomyolysis, pigmentary retinopathy, peripheral neuropathy, cardiomyopathy, and arrhythmias. Various stresses trigger metabolic decompensation. Coronavirus disease 2019 (COVID‐19) is a pandemic caused by the RNA virus SARS‐CoV‐2 with diverse presentations ranging from respiratory symptoms to myocarditis. We report a case of a patient with LCHADD who initially presented with typical metabolic decompensation symptoms including nausea, vomiting, and rhabdomyolysis in addition to mild cough, and was found to have COVID‐19. She developed acute respiratory failure and refractory hypotension from severe cardiomyopathy which progressed to multiple organ failure and death. Our case illustrates the need for close monitoring of cardiac function in patients with a long‐chain fatty acid oxidation disorder. |
format | Online Article Text |
id | pubmed-7653242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76532422020-11-16 Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report Wongkittichote, Parith Watson, James R. Leonard, Jennifer M. Toolan, Elizabeth R. Dickson, Patricia I. Grange, Dorothy K. JIMD Rep Case Reports Long‐chain fatty‐acyl CoA dehydrogenase deficiency (LCHADD) is an inborn error of long chain fatty acid oxidation with various features including hypoketotic hypoglycemia, recurrent rhabdomyolysis, pigmentary retinopathy, peripheral neuropathy, cardiomyopathy, and arrhythmias. Various stresses trigger metabolic decompensation. Coronavirus disease 2019 (COVID‐19) is a pandemic caused by the RNA virus SARS‐CoV‐2 with diverse presentations ranging from respiratory symptoms to myocarditis. We report a case of a patient with LCHADD who initially presented with typical metabolic decompensation symptoms including nausea, vomiting, and rhabdomyolysis in addition to mild cough, and was found to have COVID‐19. She developed acute respiratory failure and refractory hypotension from severe cardiomyopathy which progressed to multiple organ failure and death. Our case illustrates the need for close monitoring of cardiac function in patients with a long‐chain fatty acid oxidation disorder. John Wiley & Sons, Inc. 2020-09-10 /pmc/articles/PMC7653242/ /pubmed/33204595 http://dx.doi.org/10.1002/jmd2.12165 Text en © 2020 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Wongkittichote, Parith Watson, James R. Leonard, Jennifer M. Toolan, Elizabeth R. Dickson, Patricia I. Grange, Dorothy K. Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report |
title | Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report |
title_full | Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report |
title_fullStr | Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report |
title_full_unstemmed | Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report |
title_short | Fatal COVID‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐CoA dehydrogenase deficiency: A case report |
title_sort | fatal covid‐19 infection in a patient with long‐chain 3‐hydroxyacyl‐coa dehydrogenase deficiency: a case report |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653242/ https://www.ncbi.nlm.nih.gov/pubmed/33204595 http://dx.doi.org/10.1002/jmd2.12165 |
work_keys_str_mv | AT wongkittichoteparith fatalcovid19infectioninapatientwithlongchain3hydroxyacylcoadehydrogenasedeficiencyacasereport AT watsonjamesr fatalcovid19infectioninapatientwithlongchain3hydroxyacylcoadehydrogenasedeficiencyacasereport AT leonardjenniferm fatalcovid19infectioninapatientwithlongchain3hydroxyacylcoadehydrogenasedeficiencyacasereport AT toolanelizabethr fatalcovid19infectioninapatientwithlongchain3hydroxyacylcoadehydrogenasedeficiencyacasereport AT dicksonpatriciai fatalcovid19infectioninapatientwithlongchain3hydroxyacylcoadehydrogenasedeficiencyacasereport AT grangedorothyk fatalcovid19infectioninapatientwithlongchain3hydroxyacylcoadehydrogenasedeficiencyacasereport |